-
J. Pediatr. Gastroenterol. Nutr. · Oct 2013
Comment LetterAntitumor necrosis factor, infliximab, and adalimumab: use with caution in eosinophilic bowel disease.
- Glenn T Furuta, Dan Atkins, Kelley E Capocelli, Edwin F de Zoeten, David Fleischer, and Calies Menard-Katcher.
- *Section of Pediatric Gastroenterology, Hepatology, Digestive Health Institute, Children's Hospital Colorado †Department of Pediatrics ‡Department of Pathology, National Jewish Health, Aurora, CO.
- J. Pediatr. Gastroenterol. Nutr. 2013 Oct 1; 57 (4): e25.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..